nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—colon cancer	0.829	1	CbGaD
Nadolol—Pemphigoid—Fluorouracil—colon cancer	0.0134	0.0851	CcSEcCtD
Nadolol—Arterial thrombosis—Irinotecan—colon cancer	0.00651	0.0414	CcSEcCtD
Nadolol—Colitis ischaemic—Irinotecan—colon cancer	0.00596	0.0379	CcSEcCtD
Nadolol—ABCB1—Irinotecan—colon cancer	0.00558	0.416	CbGbCtD
Nadolol—ABCB1—Vincristine—colon cancer	0.00488	0.364	CbGbCtD
Nadolol—Slurred speech—Fluorouracil—colon cancer	0.00375	0.0239	CcSEcCtD
Nadolol—Arterial thrombosis—Methotrexate—colon cancer	0.00324	0.0206	CcSEcCtD
Nadolol—ABCB1—Methotrexate—colon cancer	0.00295	0.22	CbGbCtD
Nadolol—Respiratory distress—Vincristine—colon cancer	0.00283	0.018	CcSEcCtD
Nadolol—Peripheral coldness—Capecitabine—colon cancer	0.00246	0.0157	CcSEcCtD
Nadolol—Swelling face—Capecitabine—colon cancer	0.00246	0.0157	CcSEcCtD
Nadolol—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00204	0.013	CcSEcCtD
Nadolol—Dysarthria—Irinotecan—colon cancer	0.00185	0.0118	CcSEcCtD
Nadolol—Respiratory distress—Capecitabine—colon cancer	0.00185	0.0117	CcSEcCtD
Nadolol—Blood triglycerides increased—Capecitabine—colon cancer	0.00179	0.0114	CcSEcCtD
Nadolol—Dysarthria—Fluorouracil—colon cancer	0.00177	0.0113	CcSEcCtD
Nadolol—Throat sore—Capecitabine—colon cancer	0.00163	0.0103	CcSEcCtD
Nadolol—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00161	0.0103	CcSEcCtD
Nadolol—Extrasystoles—Capecitabine—colon cancer	0.00139	0.00887	CcSEcCtD
Nadolol—Disorientation—Fluorouracil—colon cancer	0.00136	0.00866	CcSEcCtD
Nadolol—Visual disturbance—Irinotecan—colon cancer	0.00134	0.00854	CcSEcCtD
Nadolol—Ventricular extrasystoles—Capecitabine—colon cancer	0.0013	0.00826	CcSEcCtD
Nadolol—Amnesia—Fluorouracil—colon cancer	0.0013	0.00825	CcSEcCtD
Nadolol—Oropharyngeal pain—Capecitabine—colon cancer	0.00129	0.0082	CcSEcCtD
Nadolol—Cardiac failure—Fluorouracil—colon cancer	0.00125	0.00794	CcSEcCtD
Nadolol—Lethargy—Fluorouracil—colon cancer	0.00124	0.00791	CcSEcCtD
Nadolol—Dysarthria—Capecitabine—colon cancer	0.00124	0.00789	CcSEcCtD
Nadolol—Irritability—Fluorouracil—colon cancer	0.00116	0.0074	CcSEcCtD
Nadolol—Dry skin—Fluorouracil—colon cancer	0.00112	0.0071	CcSEcCtD
Nadolol—Fluid retention—Capecitabine—colon cancer	0.00111	0.00708	CcSEcCtD
Nadolol—Abdominal distension—Irinotecan—colon cancer	0.00111	0.00704	CcSEcCtD
Nadolol—Dry eye—Capecitabine—colon cancer	0.00108	0.00689	CcSEcCtD
Nadolol—Erectile dysfunction—Vincristine—colon cancer	0.00104	0.00661	CcSEcCtD
Nadolol—Depression—Vincristine—colon cancer	0.001	0.00638	CcSEcCtD
Nadolol—Sleep disorder—Capecitabine—colon cancer	0.000983	0.00626	CcSEcCtD
Nadolol—Sweating—Vincristine—colon cancer	0.000965	0.00614	CcSEcCtD
Nadolol—Sweating—Irinotecan—colon cancer	0.00094	0.00598	CcSEcCtD
Nadolol—Hepatic enzyme increased—Methotrexate—colon cancer	0.000923	0.00587	CcSEcCtD
Nadolol—Dysarthria—Methotrexate—colon cancer	0.000923	0.00587	CcSEcCtD
Nadolol—Libido decreased—Capecitabine—colon cancer	0.000918	0.00584	CcSEcCtD
Nadolol—Conjunctivitis—Fluorouracil—colon cancer	0.000912	0.0058	CcSEcCtD
Nadolol—Amnesia—Capecitabine—colon cancer	0.000906	0.00576	CcSEcCtD
Nadolol—Hallucination—Vincristine—colon cancer	0.000899	0.00572	CcSEcCtD
Nadolol—Bradycardia—Irinotecan—colon cancer	0.000896	0.0057	CcSEcCtD
Nadolol—Agranulocytosis—Fluorouracil—colon cancer	0.000876	0.00557	CcSEcCtD
Nadolol—Cardiac failure—Capecitabine—colon cancer	0.000872	0.00555	CcSEcCtD
Nadolol—Lethargy—Capecitabine—colon cancer	0.000869	0.00553	CcSEcCtD
Nadolol—Diplopia—Capecitabine—colon cancer	0.000851	0.00542	CcSEcCtD
Nadolol—Visual impairment—Irinotecan—colon cancer	0.000848	0.00539	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000844	0.00537	CcSEcCtD
Nadolol—Irritability—Capecitabine—colon cancer	0.000812	0.00517	CcSEcCtD
Nadolol—Mood swings—Capecitabine—colon cancer	0.000806	0.00513	CcSEcCtD
Nadolol—Alopecia—Vincristine—colon cancer	0.000798	0.00508	CcSEcCtD
Nadolol—Dry skin—Capecitabine—colon cancer	0.00078	0.00496	CcSEcCtD
Nadolol—Alopecia—Irinotecan—colon cancer	0.000777	0.00495	CcSEcCtD
Nadolol—Pulmonary oedema—Methotrexate—colon cancer	0.000777	0.00494	CcSEcCtD
Nadolol—Flatulence—Irinotecan—colon cancer	0.000755	0.0048	CcSEcCtD
Nadolol—Gastritis—Capecitabine—colon cancer	0.000753	0.00479	CcSEcCtD
Nadolol—Alopecia—Fluorouracil—colon cancer	0.000745	0.00474	CcSEcCtD
Nadolol—Abdominal distension—Capecitabine—colon cancer	0.000741	0.00471	CcSEcCtD
Nadolol—Bronchospasm—Capecitabine—colon cancer	0.000724	0.0046	CcSEcCtD
Nadolol—Abdominal discomfort—Capecitabine—colon cancer	0.000705	0.00449	CcSEcCtD
Nadolol—Vision blurred—Fluorouracil—colon cancer	0.000691	0.0044	CcSEcCtD
Nadolol—Syncope—Irinotecan—colon cancer	0.000687	0.00437	CcSEcCtD
Nadolol—Hypertension—Vincristine—colon cancer	0.000679	0.00432	CcSEcCtD
Nadolol—Loss of consciousness—Irinotecan—colon cancer	0.000673	0.00428	CcSEcCtD
Nadolol—Weight increased—Capecitabine—colon cancer	0.00067	0.00426	CcSEcCtD
Nadolol—Visual disturbance—Methotrexate—colon cancer	0.000669	0.00425	CcSEcCtD
Nadolol—Cough—Irinotecan—colon cancer	0.000668	0.00425	CcSEcCtD
Nadolol—Hypertension—Irinotecan—colon cancer	0.000661	0.00421	CcSEcCtD
Nadolol—Depression—Capecitabine—colon cancer	0.000654	0.00416	CcSEcCtD
Nadolol—Lethargy—Methotrexate—colon cancer	0.000647	0.00411	CcSEcCtD
Nadolol—Oedema—Vincristine—colon cancer	0.000642	0.00408	CcSEcCtD
Nadolol—Conjunctivitis—Capecitabine—colon cancer	0.000638	0.00406	CcSEcCtD
Nadolol—Oedema—Irinotecan—colon cancer	0.000625	0.00398	CcSEcCtD
Nadolol—Chest pain—Fluorouracil—colon cancer	0.000625	0.00397	CcSEcCtD
Nadolol—Hyperhidrosis—Vincristine—colon cancer	0.00062	0.00395	CcSEcCtD
Nadolol—Shock—Irinotecan—colon cancer	0.000615	0.00391	CcSEcCtD
Nadolol—Agranulocytosis—Capecitabine—colon cancer	0.000612	0.00389	CcSEcCtD
Nadolol—Anorexia—Vincristine—colon cancer	0.000612	0.00389	CcSEcCtD
Nadolol—Irritability—Methotrexate—colon cancer	0.000605	0.00385	CcSEcCtD
Nadolol—Hyperhidrosis—Irinotecan—colon cancer	0.000604	0.00384	CcSEcCtD
Nadolol—Mood swings—Methotrexate—colon cancer	0.0006	0.00382	CcSEcCtD
Nadolol—Hypotension—Vincristine—colon cancer	0.0006	0.00382	CcSEcCtD
Nadolol—Bradycardia—Capecitabine—colon cancer	0.000599	0.00381	CcSEcCtD
Nadolol—Oedema—Fluorouracil—colon cancer	0.000599	0.00381	CcSEcCtD
Nadolol—Anorexia—Irinotecan—colon cancer	0.000596	0.00379	CcSEcCtD
Nadolol—Hypotension—Irinotecan—colon cancer	0.000584	0.00372	CcSEcCtD
Nadolol—Insomnia—Vincristine—colon cancer	0.000581	0.00369	CcSEcCtD
Nadolol—Paraesthesia—Vincristine—colon cancer	0.000576	0.00367	CcSEcCtD
Nadolol—Anorexia—Fluorouracil—colon cancer	0.000571	0.00363	CcSEcCtD
Nadolol—Visual impairment—Capecitabine—colon cancer	0.000567	0.00361	CcSEcCtD
Nadolol—Insomnia—Irinotecan—colon cancer	0.000565	0.0036	CcSEcCtD
Nadolol—Paraesthesia—Irinotecan—colon cancer	0.000561	0.00357	CcSEcCtD
Nadolol—Hypotension—Fluorouracil—colon cancer	0.000559	0.00356	CcSEcCtD
Nadolol—Decreased appetite—Vincristine—colon cancer	0.000558	0.00355	CcSEcCtD
Nadolol—Dyspnoea—Irinotecan—colon cancer	0.000557	0.00355	CcSEcCtD
Nadolol—Fatigue—Vincristine—colon cancer	0.000553	0.00352	CcSEcCtD
Nadolol—Dyspepsia—Irinotecan—colon cancer	0.00055	0.0035	CcSEcCtD
Nadolol—Tinnitus—Capecitabine—colon cancer	0.000549	0.00349	CcSEcCtD
Nadolol—Pain—Vincristine—colon cancer	0.000549	0.00349	CcSEcCtD
Nadolol—Constipation—Vincristine—colon cancer	0.000549	0.00349	CcSEcCtD
Nadolol—Decreased appetite—Irinotecan—colon cancer	0.000543	0.00346	CcSEcCtD
Nadolol—Insomnia—Fluorouracil—colon cancer	0.000541	0.00344	CcSEcCtD
Nadolol—Fatigue—Irinotecan—colon cancer	0.000539	0.00343	CcSEcCtD
Nadolol—Paraesthesia—Fluorouracil—colon cancer	0.000538	0.00342	CcSEcCtD
Nadolol—Pain—Irinotecan—colon cancer	0.000535	0.0034	CcSEcCtD
Nadolol—Constipation—Irinotecan—colon cancer	0.000535	0.0034	CcSEcCtD
Nadolol—Dyspnoea—Fluorouracil—colon cancer	0.000534	0.0034	CcSEcCtD
Nadolol—Dyspepsia—Fluorouracil—colon cancer	0.000527	0.00335	CcSEcCtD
Nadolol—Abdominal discomfort—Methotrexate—colon cancer	0.000525	0.00334	CcSEcCtD
Nadolol—Decreased appetite—Fluorouracil—colon cancer	0.00052	0.00331	CcSEcCtD
Nadolol—Alopecia—Capecitabine—colon cancer	0.00052	0.00331	CcSEcCtD
Nadolol—Pain—Fluorouracil—colon cancer	0.000512	0.00326	CcSEcCtD
Nadolol—Body temperature increased—Vincristine—colon cancer	0.000507	0.00323	CcSEcCtD
Nadolol—Flatulence—Capecitabine—colon cancer	0.000505	0.00321	CcSEcCtD
Nadolol—Erectile dysfunction—Methotrexate—colon cancer	0.000504	0.00321	CcSEcCtD
Nadolol—Body temperature increased—Irinotecan—colon cancer	0.000494	0.00314	CcSEcCtD
Nadolol—Depression—Methotrexate—colon cancer	0.000487	0.0031	CcSEcCtD
Nadolol—Vision blurred—Capecitabine—colon cancer	0.000483	0.00307	CcSEcCtD
Nadolol—Conjunctivitis—Methotrexate—colon cancer	0.000475	0.00302	CcSEcCtD
Nadolol—Body temperature increased—Fluorouracil—colon cancer	0.000473	0.00301	CcSEcCtD
Nadolol—Sweating—Methotrexate—colon cancer	0.000468	0.00298	CcSEcCtD
Nadolol—Asthenia—Vincristine—colon cancer	0.000461	0.00293	CcSEcCtD
Nadolol—Syncope—Capecitabine—colon cancer	0.00046	0.00292	CcSEcCtD
Nadolol—Agranulocytosis—Methotrexate—colon cancer	0.000456	0.0029	CcSEcCtD
Nadolol—Loss of consciousness—Capecitabine—colon cancer	0.000451	0.00287	CcSEcCtD
Nadolol—Asthenia—Irinotecan—colon cancer	0.000448	0.00285	CcSEcCtD
Nadolol—Cough—Capecitabine—colon cancer	0.000447	0.00285	CcSEcCtD
Nadolol—Hypertension—Capecitabine—colon cancer	0.000443	0.00282	CcSEcCtD
Nadolol—Diarrhoea—Vincristine—colon cancer	0.000439	0.00279	CcSEcCtD
Nadolol—Chest pain—Capecitabine—colon cancer	0.000436	0.00278	CcSEcCtD
Nadolol—Diarrhoea—Irinotecan—colon cancer	0.000428	0.00272	CcSEcCtD
Nadolol—Dry mouth—Capecitabine—colon cancer	0.000427	0.00272	CcSEcCtD
Nadolol—Dizziness—Vincristine—colon cancer	0.000424	0.0027	CcSEcCtD
Nadolol—Pruritus—Fluorouracil—colon cancer	0.000424	0.00269	CcSEcCtD
Nadolol—Visual impairment—Methotrexate—colon cancer	0.000422	0.00269	CcSEcCtD
Nadolol—Oedema—Capecitabine—colon cancer	0.000418	0.00266	CcSEcCtD
Nadolol—Dizziness—Irinotecan—colon cancer	0.000413	0.00263	CcSEcCtD
Nadolol—Shock—Capecitabine—colon cancer	0.000412	0.00262	CcSEcCtD
Nadolol—Diarrhoea—Fluorouracil—colon cancer	0.00041	0.00261	CcSEcCtD
Nadolol—Tinnitus—Methotrexate—colon cancer	0.000409	0.0026	CcSEcCtD
Nadolol—Vomiting—Vincristine—colon cancer	0.000408	0.0026	CcSEcCtD
Nadolol—Rash—Vincristine—colon cancer	0.000405	0.00257	CcSEcCtD
Nadolol—Hyperhidrosis—Capecitabine—colon cancer	0.000404	0.00257	CcSEcCtD
Nadolol—Dermatitis—Vincristine—colon cancer	0.000404	0.00257	CcSEcCtD
Nadolol—Anorexia—Capecitabine—colon cancer	0.000399	0.00254	CcSEcCtD
Nadolol—Vomiting—Irinotecan—colon cancer	0.000397	0.00253	CcSEcCtD
Nadolol—Dizziness—Fluorouracil—colon cancer	0.000396	0.00252	CcSEcCtD
Nadolol—Rash—Irinotecan—colon cancer	0.000394	0.00251	CcSEcCtD
Nadolol—Dermatitis—Irinotecan—colon cancer	0.000394	0.0025	CcSEcCtD
Nadolol—Hypotension—Capecitabine—colon cancer	0.000391	0.00249	CcSEcCtD
Nadolol—Alopecia—Methotrexate—colon cancer	0.000387	0.00246	CcSEcCtD
Nadolol—Nausea—Vincristine—colon cancer	0.000381	0.00243	CcSEcCtD
Nadolol—Vomiting—Fluorouracil—colon cancer	0.000381	0.00242	CcSEcCtD
Nadolol—Insomnia—Capecitabine—colon cancer	0.000378	0.00241	CcSEcCtD
Nadolol—Rash—Fluorouracil—colon cancer	0.000377	0.0024	CcSEcCtD
Nadolol—Dermatitis—Fluorouracil—colon cancer	0.000377	0.0024	CcSEcCtD
Nadolol—Paraesthesia—Capecitabine—colon cancer	0.000376	0.00239	CcSEcCtD
Nadolol—Dyspnoea—Capecitabine—colon cancer	0.000373	0.00237	CcSEcCtD
Nadolol—Nausea—Irinotecan—colon cancer	0.000371	0.00236	CcSEcCtD
Nadolol—Dyspepsia—Capecitabine—colon cancer	0.000368	0.00234	CcSEcCtD
Nadolol—Decreased appetite—Capecitabine—colon cancer	0.000364	0.00231	CcSEcCtD
Nadolol—Fatigue—Capecitabine—colon cancer	0.000361	0.00229	CcSEcCtD
Nadolol—Vision blurred—Methotrexate—colon cancer	0.00036	0.00229	CcSEcCtD
Nadolol—Pain—Capecitabine—colon cancer	0.000358	0.00228	CcSEcCtD
Nadolol—Constipation—Capecitabine—colon cancer	0.000358	0.00228	CcSEcCtD
Nadolol—Nausea—Fluorouracil—colon cancer	0.000356	0.00226	CcSEcCtD
Nadolol—Cough—Methotrexate—colon cancer	0.000333	0.00212	CcSEcCtD
Nadolol—Body temperature increased—Capecitabine—colon cancer	0.000331	0.0021	CcSEcCtD
Nadolol—Chest pain—Methotrexate—colon cancer	0.000325	0.00207	CcSEcCtD
Nadolol—Hyperhidrosis—Methotrexate—colon cancer	0.000301	0.00192	CcSEcCtD
Nadolol—Asthenia—Capecitabine—colon cancer	0.0003	0.00191	CcSEcCtD
Nadolol—Anorexia—Methotrexate—colon cancer	0.000297	0.00189	CcSEcCtD
Nadolol—Pruritus—Capecitabine—colon cancer	0.000296	0.00188	CcSEcCtD
Nadolol—Hypotension—Methotrexate—colon cancer	0.000291	0.00185	CcSEcCtD
Nadolol—Diarrhoea—Capecitabine—colon cancer	0.000286	0.00182	CcSEcCtD
Nadolol—Insomnia—Methotrexate—colon cancer	0.000282	0.00179	CcSEcCtD
Nadolol—Paraesthesia—Methotrexate—colon cancer	0.00028	0.00178	CcSEcCtD
Nadolol—Dyspnoea—Methotrexate—colon cancer	0.000278	0.00177	CcSEcCtD
Nadolol—Dizziness—Capecitabine—colon cancer	0.000277	0.00176	CcSEcCtD
Nadolol—Dyspepsia—Methotrexate—colon cancer	0.000274	0.00174	CcSEcCtD
Nadolol—Decreased appetite—Methotrexate—colon cancer	0.000271	0.00172	CcSEcCtD
Nadolol—Fatigue—Methotrexate—colon cancer	0.000269	0.00171	CcSEcCtD
Nadolol—Pain—Methotrexate—colon cancer	0.000266	0.00169	CcSEcCtD
Nadolol—Vomiting—Capecitabine—colon cancer	0.000266	0.00169	CcSEcCtD
Nadolol—Rash—Capecitabine—colon cancer	0.000264	0.00168	CcSEcCtD
Nadolol—Dermatitis—Capecitabine—colon cancer	0.000264	0.00168	CcSEcCtD
Nadolol—Nausea—Capecitabine—colon cancer	0.000248	0.00158	CcSEcCtD
Nadolol—Body temperature increased—Methotrexate—colon cancer	0.000246	0.00157	CcSEcCtD
Nadolol—Asthenia—Methotrexate—colon cancer	0.000223	0.00142	CcSEcCtD
Nadolol—Pruritus—Methotrexate—colon cancer	0.00022	0.0014	CcSEcCtD
Nadolol—Diarrhoea—Methotrexate—colon cancer	0.000213	0.00136	CcSEcCtD
Nadolol—Dizziness—Methotrexate—colon cancer	0.000206	0.00131	CcSEcCtD
Nadolol—Vomiting—Methotrexate—colon cancer	0.000198	0.00126	CcSEcCtD
Nadolol—Rash—Methotrexate—colon cancer	0.000196	0.00125	CcSEcCtD
Nadolol—Dermatitis—Methotrexate—colon cancer	0.000196	0.00125	CcSEcCtD
Nadolol—Nausea—Methotrexate—colon cancer	0.000185	0.00118	CcSEcCtD
